chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Eructation, Feeling abnormal, Feeling cold, Headache, Myalgia
Clinical narrative: Burping like crazy; A terrible headache; Became freezing cold; arm was sore; Had many body aches/Body aches and right side really hurts; My head feels like it is in a vice; This spontaneous case was reported by a patient and describes the occurrence of FEELING COLD (Became freezing cold), FEELING ABNORMAL (My head feels like it is in a vice), ERUCTATION (Burping like crazy), PAIN IN EXTREMITY (arm was sore) and MYALGIA (Had many body aches/Body aches and right side really hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder (only have one prescription and its thyroid).   On 19-May-2022 at 9:00 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced FEELING ABNORMAL (My head feels like it is in a vice). On 19-May-2022, the patient experienced MYALGIA (Had many body aches/Body aches and right side really hurts). On 19-May-2022 at 5:30 PM, the patient experienced PAIN IN EXTREMITY (arm was sore). On 19-May-2022 at 6:30 PM, the patient experienced FEELING COLD (Became freezing cold). On 20-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ERUCTATION (Burping like crazy) and HEADACHE (A terrible headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, FEELING COLD (Became freezing cold), FEELING ABNORMAL (My head feels like it is in a vice), ERUCTATION (Burping like crazy), PAIN IN EXTREMITY (arm was sore), MYALGIA (Had many body aches/Body aches and right side really hurts) and HEADACHE (A terrible headache) was resolving.     No concomitant medication was reported. It was reported that, patient had her second booster and unfortunately had the same problems. Patient went to bed at 9.00 PM. On 20-May-2022 she woke up still freezing cold, a terrible headache, she had been blessed her whole life with never having headache except when got the vaccines. Patient took Advil and there was a little improvement. Patient reported that she had only one prescription for thyroid. Patient reported that she did not have a lot of medical problems. Patient was normally fine. She was hoping that this did not last for 2 weeks again like it did after her last booster. Patient also stated that the temperature was 88 degrees outside so patient should not be cold at all. Normally patient was too warm so this was unusual.   This case was linked to MOD-2022-570128 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Burping like crazy; A terrible headache; Became freezing cold; arm was sore; Had many body aches/Body aches and right side really hurts; My head feels like it is in a vice; This spontaneous case was reported by a patient and describes the occurrence of FEELING COLD (Became freezing cold), FEELING ABNORMAL (My head feels like it is in a vice), ERUCTATION (Burping like crazy), PAIN IN EXTREMITY (arm was sore) and MYALGIA (Had many body aches/Body aches and right side really hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder (only have one prescription and its thyroid).   On 19-May-2022 at 9:00 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced FEELING ABNORMAL (My head feels like it is in a vice). On 19-May-2022, the patient experienced MYALGIA (Had many body aches/Body aches and right side really hurts). On 19-May-2022 at 5:30 PM, the patient experienced PAIN IN EXTREMITY (arm was sore). On 19-May-2022 at 6:30 PM, the patient experienced FEELING COLD (Became freezing cold). On 20-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ERUCTATION (Burping like crazy) and HEADACHE (A terrible headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, FEELING COLD (Became freezing cold), FEELING ABNORMAL (My head feels like it is in a vice), ERUCTATION (Burping like crazy), PAIN IN EXTREMITY (arm was sore), MYALGIA (Had many body aches/Body aches and right side really hurts) and HEADACHE (A terrible headache) was resolving.     No concomitant medication was reported. It was reported that, patient had her second booster and unfortunately had the same problems. Patient went to bed at 9.00 PM. On 20-May-2022 she woke up still freezing cold, a terrible headache, she had been blessed her whole life with never having headache except when got the vaccines. Patient took Advil and there was a little improvement. Patient reported that she had only one prescription for thyroid. Patient reported that she did not have a lot of medical problems. Patient was normally fine. She was hoping that this did not last for 2 weeks again like it did after her last booster. Patient also stated that the temperature was 88 degrees outside so patient should not be cold at all. Normally patient was too warm so this was unusual.   This case was linked to MOD-2022-570128 (Patient Link).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: The expiration date for the vaccine was 3MAY2022, Patient received expired vaccine on 4MAY2022; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (The expiration date for the vaccine was 3MAY2022, Patient received expired vaccine on 4MAY2022) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 083J21A, 034F21A, 024M20A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The expiration date for the vaccine was 3MAY2022, Patient received expired vaccine on 4MAY2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (The expiration date for the vaccine was 3MAY2022, Patient received expired vaccine on 4MAY2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported. On 21APR2022 at 6AM 6 vials were removed rom the Freezer of the nurse's Facilities Pharmacy and sent to the Nurses Office. The 6 vials were placed in the offices refrigerator on 21APR2022. The bag that the Nurses Pharmacy sent the vials in was marked as expires in twelve days.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose of Moderna vaccine on 06-Jan-2021 and second dose on 20-Aug-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of Moderna vaccine on 06-Jan-2021 and second dose on 20-Aug-2021) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054C21A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included Prostatectomy. Concurrent medical conditions included HIV infection and Melanoma. Concomitant products included BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY), VALACYCLOVIR [VALACICLOVIR], CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), TADALAFIL (CIALIS), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), CURCUMA LONGA (TURMERIC [CURCUMA LONGA]), FAMOTIDINE, VITAMIN C [ASCORBIC ACID], ZINC, CALCIUM;MAGNESIUM, BIFIDOBACTERIUM INFANTIS (ALIGN), ASCORBIC ACID, CALCIUM PHOSPHATE, LACTOBACILLUS NOS, VACCINIUM MACROCARPON (AZO CRANBERRY), VITAMIN B COMPLEX (B-COMPLEX [VITAMIN B COMPLEX]), ACETYLCYSTEINE (NAC [ACETYLCYSTEINE]), LYSINE, ROSUVASTATIN CALCIUM (CRESTOR), UBIDECARENONE (COQ10 [UBIDECARENONE]) and BROMELAINS, QUERCETIN (NOW QUERCETIN WITH BROMELAIN) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of Moderna vaccine on 06-Jan-2021 and second dose on 20-Aug-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of Moderna vaccine on 06-Jan-2021 and second dose on 20-Aug-2021) outcome was unknown.            No treatment information was provided by the reporter.   This case was linked to MOD-2022-570348 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Swelling
Clinical narrative: Swelling; Injection site pain; Fatigue; Headache; Muscle and joint pain; Muscle and joint pain; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Muscle and joint pain) in a 72-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Faint (Prior to 1st dose she had 2 episodes of falling in night but stated that both were faint episodes).    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle and joint pain) and ARTHRALGIA (Muscle and joint pain). At the time of the report, SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle and joint pain) and ARTHRALGIA (Muscle and joint pain) outcome was unknown.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.       No concomitant information were reported by the reporter.  Patient received 3 doses of the Moderna vaccine in the recommended time frame. Patient reported that she had minor side effects after her Moderna doses.  No treatment information were reported by the reporter.   This case was linked to MOD-2022-572773, MOD-2022-572771, MOD-2022-572772 (Patient Link).   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Swelling; Injection site pain; Fatigue; Headache; Muscle and joint pain; Muscle and joint pain; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (Muscle and joint pain) in a 72-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Faint (Prior to 1st dose she had 2 episodes of falling in night but stated that both were faint episodes).    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle and joint pain) and ARTHRALGIA (Muscle and joint pain). At the time of the report, SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle and joint pain) and ARTHRALGIA (Muscle and joint pain) outcome was unknown.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.       No concomitant information were reported by the reporter.  Patient received 3 doses of the Moderna vaccine in the recommended time frame. Patient reported that she had minor side effects after her Moderna doses.  No treatment information were reported by the reporter.   This case was linked to MOD-2022-572773, MOD-2022-572771, MOD-2022-572772 (Patient Link).   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Swelling
Clinical narrative: Swelling; Injection site pain; Headache; Fatigue; Muscle pain; Joint pain; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), FATIGUE (Fatigue) and MYALGIA (Muscle pain) in a 72-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Faint (falling in the night, Both were faint episodes).   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) outcome was unknown.            No concomitant medications were reported. It was reported that the patient had minor side effects after vaccination. She was concerned regarding fainting as an event of Moderna vaccine. No treatment details were reported.     This case was linked to MOD-2022-572773, MOD-2022-572766 (Patient Link).   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Swelling; Injection site pain; Headache; Fatigue; Muscle pain; Joint pain; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), FATIGUE (Fatigue) and MYALGIA (Muscle pain) in a 72-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Faint (falling in the night, Both were faint episodes).   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) outcome was unknown.            No concomitant medications were reported. It was reported that the patient had minor side effects after vaccination. She was concerned regarding fainting as an event of Moderna vaccine. No treatment details were reported.     This case was linked to MOD-2022-572773, MOD-2022-572766 (Patient Link).   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Swelling
Clinical narrative: Swelling; Injection site pain; Fatigue; Headache; Muscle and joint pain; Muscle and joint pain; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache) and ARTHRALGIA (Muscle and joint pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Faint (2 episodes of falling in the night but stated that both were faint episodes.).   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache), ARTHRALGIA (Muscle and joint pain) and MYALGIA (Muscle and joint pain). At the time of the report, SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache), ARTHRALGIA (Muscle and joint pain) and MYALGIA (Muscle and joint pain) outcome was unknown.            No concomitant medication was reported. It was reported that patient had minor side effects after her Moderna doses. Treatment information was reported as Unknown.   This case was linked to MOD-2022-572766, MOD-2022-572771 (Patient Link).   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Swelling; Injection site pain; Fatigue; Headache; Muscle and joint pain; Muscle and joint pain; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache) and ARTHRALGIA (Muscle and joint pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Faint (2 episodes of falling in the night but stated that both were faint episodes.).   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache), ARTHRALGIA (Muscle and joint pain) and MYALGIA (Muscle and joint pain). At the time of the report, SWELLING (Swelling), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Fatigue), HEADACHE (Headache), ARTHRALGIA (Muscle and joint pain) and MYALGIA (Muscle and joint pain) outcome was unknown.            No concomitant medication was reported. It was reported that patient had minor side effects after her Moderna doses. Treatment information was reported as Unknown.   This case was linked to MOD-2022-572766, MOD-2022-572771 (Patient Link).   Reporter did not allow further contact
Age: 62.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Fatigue, Pain, Swelling
Clinical narrative: Swollen/swelling; pain; Fatigue aggravated/Felt a little more tired for the whole day; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue aggravated/Felt a little more tired for the whole day), SWELLING (Swollen/swelling) and PAIN (pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    It was unknown whether the patient was enrolled in a COVID-19 trial or not.  Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe Rheumatoid arthritis).   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In May 2022, the patient experienced FATIGUE (Fatigue aggravated/Felt a little more tired for the whole day). On an unknown date, the patient experienced SWELLING (Swollen/swelling) and PAIN (pain). In May 2022, FATIGUE (Fatigue aggravated/Felt a little more tired for the whole day) had resolved. At the time of the report, SWELLING (Swollen/swelling) and PAIN (pain) had not resolved.            No concomitant medications were reported.  No treatment information was reported.  The patient received Humira as co-suspect (form : solution for injection in prefilled pen).  The causality assessed between the co-suspect Humira with the event felt a little more tired for the whole day was reported as probable, while the causality assessed between the suspect Moderna vaccine with the event felt a little more tired for the whole day was reported as possible.  The causality assessed between the co-suspect Humira with the events swelling and pain was reported as not related.  The reporter did not have the lot number information, because the packaging was discarded.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Dyspepsia
Clinical narrative: Reflux like heartburn and a metallic taste sensation which lingers for hours; Reflux like heartburn and a metallic taste sensation which lingers for hours; This spontaneous case was reported by a patient and describes the occurrence of DYSPEPSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) and DYSGEUSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Unknown drug.).    On 02-Feb-2022 at 4:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2022, the patient experienced DYSPEPSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) and DYSGEUSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours). On 19-May-2022, DYSPEPSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) and DYSGEUSIA (Reflux like heartburn and a metallic taste sensation which lingers for hours) had resolved.            No concomitant medications were reported. The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. Co-suspect product included non-company product, unspecified Pfizer medication for treatment of COVID-19. The patient received an unspecified Pfizer medication (unknown route) from 15-May-2022 to 19-May-2022.   No treatment information was reported. Device Date was reported as 19May2022.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 060H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The vials were moved from freezer to Room Temperature at time of vaccination. Vial did not undergo any temperature excursion. Patient did not have any adverse reactions. No treatment  medications were reported.
Age: 63.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Pyrexia, Weight, Weight increased
Clinical narrative: Weight gain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT INCREASED (Weight gain) and PYREXIA (Fever) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On an unknown date, the patient experienced WEIGHT INCREASED (Weight gain) and PYREXIA (Fever). At the time of the report, WEIGHT INCREASED (Weight gain) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Weight: increased (High) Increased.         No concomitant medication was reported.  Patient received Humira as Solution for injection in pre-filled pen.  It was unknown if patient was enrolled in a COVID 19 Vaccine trial.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Influenza, Myalgia
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches/Muscle pains), ARTHRALGIA (joint aches/joint pains) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     It is unknown that patient had an allergies, medical history and other vaccines given within 1 month prior to Moderna COVID-19 vaccine.     On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches/Muscle pains), ARTHRALGIA (joint aches/joint pains), CHILLS (chills) and NAUSEA (nausea). At the time of the report, INFLUENZA (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches/Muscle pains), ARTHRALGIA (joint aches/joint pains), CHILLS (chills) and NAUSEA (nausea) had resolved.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Unknown that the patient experienced a similar event in the past. No treatment information was provided.   This case was linked to MOD-2022-573336, MOD-2022-573338, MOD-2022-573339 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches/Muscle pains), ARTHRALGIA (joint aches/joint pains) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     It is unknown that patient had an allergies, medical history and other vaccines given within 1 month prior to Moderna COVID-19 vaccine.     On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches/Muscle pains), ARTHRALGIA (joint aches/joint pains), CHILLS (chills) and NAUSEA (nausea). At the time of the report, INFLUENZA (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches/Muscle pains), ARTHRALGIA (joint aches/joint pains), CHILLS (chills) and NAUSEA (nausea) had resolved.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Unknown that the patient experienced a similar event in the past. No treatment information was provided.   This case was linked to MOD-2022-573336, MOD-2022-573338, MOD-2022-573339 (Patient Link).
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Influenza like illness, Myalgia
Clinical narrative: like I've got the flu; sick to my stomach; muscle aches & pains; joint aches & pains; chills; nausea; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains) and CHILLS (chills) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea). At the time of the report, INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported. It was reported that the events were Improved. It was unknown if the patient had ever tested COVID positive. Information on other vaccines given within one month prior to Moderna vaccine was unknown. Patient did not seek medical care due to Adverse events. Information on a similar events experienced by patient in the past was unknown.   This case was linked to MOD-2022-573328, MOD-2022-573336, MOD-2022-573339 (Patient Link).
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea
Clinical narrative: like I've got the flu; sick to my stomach; muscle aches & pains; joint aches & pains; chills; nausea; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains) and CHILLS (chills) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea). At the time of the report, INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported. It was reported that the events were Improved. It was unknown if the patient had ever tested COVID positive. Information on other vaccines given within one month prior to Moderna vaccine was unknown. Patient did not seek medical care due to Adverse events. Information on a similar events experienced by patient in the past was unknown.   This case was linked to MOD-2022-573328, MOD-2022-573336, MOD-2022-573339 (Patient Link).
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Illness, Influenza
Clinical narrative: like I've got the flu; sick to my stomach; muscle aches & pains; joint aches & pains; chills; nausea; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains) and CHILLS (chills) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea). At the time of the report, INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported. It was reported that the events were Improved. It was unknown if the patient had ever tested COVID positive. Information on other vaccines given within one month prior to Moderna vaccine was unknown. Patient did not seek medical care due to Adverse events. Information on a similar events experienced by patient in the past was unknown.   This case was linked to MOD-2022-573328, MOD-2022-573336, MOD-2022-573339 (Patient Link).
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: like I've got the flu; sick to my stomach; muscle aches & pains; joint aches & pains; chills; nausea; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains) and CHILLS (chills) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea). At the time of the report, INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported. It was reported that the events were Improved. It was unknown if the patient had ever tested COVID positive. Information on other vaccines given within one month prior to Moderna vaccine was unknown. Patient did not seek medical care due to Adverse events. Information on a similar events experienced by patient in the past was unknown.   This case was linked to MOD-2022-573328, MOD-2022-573336, MOD-2022-573339 (Patient Link).
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Influenza, Myalgia
Clinical narrative: like I've got the flu; sick to my stomach; muscle aches & pains; joint aches & pains; chills; nausea; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains) and CHILLS (chills) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea). At the time of the report, INFLUENZA LIKE ILLNESS (like I've got the flu), ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (muscle aches & pains), ARTHRALGIA (joint aches & pains), CHILLS (chills) and NAUSEA (nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported. It was reported that the events were Improved. It was unknown if the patient had ever tested COVID positive. Information on other vaccines given within one month prior to Moderna vaccine was unknown. Patient did not seek medical care due to Adverse events. Information on a similar events experienced by patient in the past was unknown.   This case was linked to MOD-2022-573328, MOD-2022-573336, MOD-2022-573339 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose on 31-MAR-2021 and second dose on 21-APR-2021(less than 25 days); This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 31-MAR-2021 and second dose on 21-APR-2021(less than 25 days)) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression and Allergy NOS. Concomitant products included LAMOTRIGINE, SERTRALINE and TRAZODONE for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 31-MAR-2021 and second dose on 21-APR-2021(less than 25 days)). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 31-MAR-2021 and second dose on 21-APR-2021(less than 25 days)) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2022-573518 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: reports tinnitus she was experiencing; This is a spontaneous report received from contactable reporter(s) (Pharmacist and Consumer or other non HCP) from medical information team.  A 61-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "reports tinnitus she was experiencing".  Additional information: Caller would like to know if there are any data reports of tinnitus after receiving a dose of Pfizer covid vaccine. Caller is reporting on behalf of a patient who reports tinnitus she was experiencing. They thought it might correlate to her getting the Pfizer COVID-19 vaccine. Patient had her original series and the first booster. They were asking about if patient should get her second booster.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Chills, Fatigue, Headache
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10May2022 at 14:30 as dose 4 (booster), single (Lot number: FK9893) at the age of 63 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "Hasimoto disease" (unspecified if ongoing); "Allergy" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; VITAMIN D [VITAMIN D NOS]; BABY ASPIRIN; B COMPLEX [VITAMIN B COMPLEX]. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset 11May2022 at 02:00, outcome "recovering"; PAIN (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "body aches"; BURNING SENSATION (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "burning fingertips"; SINUS DISORDER (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "dried out sinuses"; FATIGUE (non-serious) with onset 11May2022 at 02:00, outcome "recovering"; HEADACHE (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "headaches"; ARTHRALGIA (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "joint aches". Therapeutic measures were not taken as a result of chills, burning sensation, pain, headache, arthralgia, sinus disorder, fatigue.  Additional information: The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Sinus disorder
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10May2022 at 14:30 as dose 4 (booster), single (Lot number: FK9893) at the age of 63 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "Hasimoto disease" (unspecified if ongoing); "Allergy" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; VITAMIN D [VITAMIN D NOS]; BABY ASPIRIN; B COMPLEX [VITAMIN B COMPLEX]. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset 11May2022 at 02:00, outcome "recovering"; PAIN (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "body aches"; BURNING SENSATION (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "burning fingertips"; SINUS DISORDER (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "dried out sinuses"; FATIGUE (non-serious) with onset 11May2022 at 02:00, outcome "recovering"; HEADACHE (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "headaches"; ARTHRALGIA (non-serious) with onset 11May2022 at 02:00, outcome "recovering", described as "joint aches". Therapeutic measures were not taken as a result of chills, burning sensation, pain, headache, arthralgia, sinus disorder, fatigue.  Additional information: The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.